Increased activity of endogenous endothelin in patients with hypercholesterolemia

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1483-1488

  Cardillo, Carmine ^a   Kilcoyne, Crescence M ^a   Cannon III, Richard O ^a   Panza, Julio A ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BLOCKING; STRAIN GAUGE TRANSDUCER; VASODILATATION;

ENDOTHELIN-1; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW;

EID: 0034332783     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00910-4     Document Type: Article

References (32)

1. Regulatory functions of the vascular endothelium
2. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
3. Role of nitric oxide in the endothelium-dependent vasodilation in hypercholesterolemic patients
4. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia
5. Cloning and expression of cDNA encoding an endothelin receptor
6. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
7. Both ET(A) and ET(B) receptors mediate contraction to endothelin-1 in human blood vessels
8. Endothelin ET(A) and ET(B) receptors cause vasoconstriction of human resistance and capacitance vessels in vivo
9. Endothelin-A receptor antagonist-mediated vasodilation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
10. Endothelin is a potent mitogen for rat vascular smooth muscle cells
11. Growth regulator properties of endothelins
12. Aggregation of human polymorphonuclear leucocytes by endothelin: Role of platelet activating factor
13. Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers
14. Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats
15. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs
16. Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium
17. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
18. Serum platelet-derived growth factor and endothelin concentrations in human hypercholesterolemia
19. Elevated endothelin levels in patients with hyperlipidemia
20. Polar secretion of endothelin-1 by cultured endothelial cells
21. Measurement of changes in human limb volume by means of a mercury-in-rubber strain gauge
22. The effect of application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm
23. Biological profiles of highly potent novel endothelin antagonists selective for the ET(A) receptor
24. Contribution of endogenous generation of endothelin-1 to basal vascular tone
25. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788
26. Role of endothelin in the increased vascular tone of patients with essential hypertension
27. Impairment of nitric oxide-mediated vasodilator response to mental stress in hypertensive but not hypercholesterolemic patients
28. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes
29. Vasodilator effect of endothelin-converting enzyme inhibition and endothelin ET(A) receptor blockade in chronic heart failure patients treated with ACE inhibitors
30. Comparison of the effect of endothelin antagonism and angiotensine-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N-nitro-L-arginine methyl ester
31. Vascular endothelin-1 gene expression and effect on blood pressure of chronic ET(A) endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats
32. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia